Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Formation of HawkEye 360

17 Sep 2015 07:00

RNS Number : 3120Z
Allied Minds PLC
17 September 2015
 



 

For immediate release

Allied Minds Announces the Formation of HawkEye 360

 

The company will use small satellites in low Earth orbit (LEO) to collect data, perform analytics and generate reports on wireless signals worldwide that can be used to monitor and track ships, planes and other transportation networks across air, land and sea, and assist with emergency response.

 

The three founders of HawkEye 360 bring valuable experience: Mr. Chris DeMay previously worked for the U.S. National Reconnaissance Office, leading programs for satellite development. Dr. Charles Clancy and Dr. Bob McGwier of Virginia Tech's Hume Center for National Security and Technology developed the associated technology for the complex RF signal processing.

 

 

Boston (September 17, 2015) - Allied Minds (LSE: ALM), an innovative U.S. science and technology development and commercialization company, announced the formation of HawkEye 360, Inc., which will use a constellation of small satellites in low Earth orbit (LEO) capable of detecting wireless signals that can be used to track and monitor global transportation networks, assist with emergencies, as well as other data analytics and reporting services to a broad range of customers.

 

HawkEye 360 seeks to provide highly accurate maritime situational awareness, collecting information about vessels to create a wealth of current and historical data useful for commercial planning as well as emergency response. Similar data will be available for planes, ground transportation, and logistics industries.

 

"HawkEye 360's technology will allow for unprecedented analysis of wireless signals," said John Serafini, Vice President at Allied Minds and Chief Executive Officer of HawkEye 360. "Space-based detection of RF signals allows us to accurately locate and characterize difficult-to-visualize spectrum information in a way that's both global and timely. You can't do that terrestrially, and you can't do that with photos."

 

Dr. Charles Clancy and Dr. Bob McGwier of Virginia Tech's Hume Center for National Security and Technology originally developed the data processing technology being licensed by Allied Minds. They are co-founding HawkEye 360 with Chris DeMay, who most previously worked for the National Reconnaissance Office. At the NRO, DeMay led programs for signals and satellite technology development for national security satellite collection systems, supporting the U.S. Department of Defense and the U.S. Intelligence Community. DeMay will be joining HawkEye 360 as Chief Operating Officer.

 

"We are developing a system that allows us to identify signals, locate signals, and visualize the information in a way that no one has before," said Chris DeMay, Chief Operating Officer of HawkEye 360. "The collaboration with Allied Minds provides an avenue for applying cutting-edge technologies to the commercial sector in a manner that creates previously unrealized value."

 

With the addition of this majority-owned subsidiary business, Allied Minds (LSE: ALM) now owns 23 subsidiaries.

 

 

About Allied Minds, Inc.Allied Minds is an innovative U.S. science and technology development and commercialization company. Operating since 2006, Allied Minds forms, funds, manages and builds products and businesses based on innovative technologies developed at leading U.S. universities and federal research institutions. Allied Minds serves as a diversified holding company that supports its businesses and product development with capital, central management and shared services. More information about the Boston-based company can be found at www.alliedminds.com.Allied Minds Forward-Looking StatementThis press release contains statements that are or may be forward-looking statements, including statements that relate to the company's future prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risk and uncertainties described in the risk factors included in the company's regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of the company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Prospectus Rules, the Listing Rules and the Disclosure and Transparency Rules, neither the company nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

 

Media contact:

Christine Dunn

ArcPoint Strategic Communications

617.484.1660, x101

cdunn@arcpointstrategy.com

 

UK

Ben Atwell, Matthew Cole

FTI Consulting

+44 (0) 20 3727 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDBGDCIDBBGUL
Date   Source Headline
13th Nov 20174:42 pmRNSBlocklisting Six Monthly Return
13th Nov 20174:24 pmRNSBlocklisting Six Monthly Return
31st Oct 20174:47 pmRNSTotal Voting Rights
30th Oct 20177:00 amRNSAllied-Bristol Life Sciences forms ABLS IV
25th Oct 20177:00 amRNSAllied Minds Capital Markets Day: 18 January 2018
16th Oct 20177:59 amRNSAllied Minds: STT and TEL to jointly develop MRAM
6th Oct 20174:42 pmRNSTotal Voting Rights
5th Oct 20177:00 amRNSSTT announces $22.8m convertible bridge facility
28th Sep 20177:00 amRNSSciFluor SF0166 study positive top-line results
19th Sep 20177:00 amRNSDirectorate Change
14th Sep 20177:00 amRNSFederated Wireless $42m fundraise & product launch
13th Sep 20174:40 pmRNSSecond Price Monitoring Extn
13th Sep 20174:35 pmRNSPrice Monitoring Extension
1st Sep 201711:43 amRNSTotal Voting Rights
17th Aug 20177:00 amRNSHalf-year Report
8th Aug 20175:36 pmRNSHolding(s) in Company
2nd Aug 20177:00 amRNSNotice of Results
26th Jul 20177:00 amRNSALM subsid Signature Medical $2.5 million Series A
12th Jul 20177:00 amRNSBridgeSat, Inc. appoints Barry Matsumori as CEO
11th Jul 20174:35 pmRNSSpin Transfer Tech's appoints Tom Sparkman CEO
30th Jun 20175:29 pmRNSTotal Voting Rights
29th Jun 20177:00 amRNSAppointment of Head of Technology Investments
13th Jun 20177:05 amRNSDirector/PDMR Shareholding
13th Jun 20177:05 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
8th Jun 20177:00 amRNSDirector/PDMR Shareholding
8th Jun 20177:00 amRNSDirector/PDMR Shareholding
1st Jun 20175:02 pmRNSResult of AGM
30th May 20177:00 amRNSJill Smith Appointed As CEO and President
19th May 20174:58 pmRNSBlock Listing Six Monthly Return
12th May 20172:13 pmRNSBlock Listing of Shares
5th May 20177:00 amRNSBridgeSat raises $6 million in Series A financing
28th Apr 20173:14 pmRNSNotice of AGM; Annual Report
27th Apr 20177:00 amRNSAnnual Financial Report
20th Apr 20174:28 pmRNSHolding(s) in Company
18th Apr 20175:12 pmRNSHolding(s) in Company
7th Apr 20179:41 amRNSHolding(s) in Company
6th Apr 20175:24 pmRNSHolding(s) in Company
5th Apr 20174:35 pmRNSPrice Monitoring Extension
5th Apr 20177:00 amRNSReallocation of capital and resources
31st Mar 20173:56 pmRNSTotal Voting Rights
16th Mar 20175:27 pmRNSHolding(s) in Company
13th Mar 20177:00 amRNSJill Smith appointed interim CEO of Allied Minds
1st Mar 20174:45 pmRNSTotal Voting Rights
15th Feb 20172:57 pmRNSHolding(s) in Company
14th Feb 20174:23 pmRNSTotal Voting Rights
7th Feb 20177:00 amRNSHawkEye 360 Completes Second Closing of Series A

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.